C.L. Santos

951 total citations
25 papers, 838 citations indexed

About

C.L. Santos is a scholar working on Organic Chemistry, Pharmacology and Oncology. According to data from OpenAlex, C.L. Santos has authored 25 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 9 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in C.L. Santos's work include Synthesis and biological activity (12 papers), Synthesis of Organic Compounds (9 papers) and Bioactive Compounds and Antitumor Agents (6 papers). C.L. Santos is often cited by papers focused on Synthesis and biological activity (12 papers), Synthesis of Organic Compounds (9 papers) and Bioactive Compounds and Antitumor Agents (6 papers). C.L. Santos collaborates with scholars based in Canada, United States and Belgium. C.L. Santos's co-authors include Theresa M. Allen, Jonathan R. Dimmock, Erik De Clercq, Gordon A. Zello, J. Wilson Quail, John R. Mackey, Elias K. Manavathu, Maniyan P. Padmanilayam, E.O. Oloo and Adil J. Nazarali and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

C.L. Santos

25 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.L. Santos Canada 14 494 318 166 125 63 25 838
Renukadevi Patil United States 23 920 1.9× 640 2.0× 163 1.0× 200 1.6× 77 1.2× 48 1.7k
Francesca Pagliai Italy 7 869 1.8× 390 1.2× 111 0.7× 119 1.0× 65 1.0× 8 1.0k
Palwinder Singh India 21 525 1.1× 378 1.2× 138 0.8× 79 0.6× 52 0.8× 51 1.0k
Hsueh‐Yun Lee Taiwan 21 821 1.7× 824 2.6× 320 1.9× 139 1.1× 60 1.0× 56 1.6k
John D. Chisholm United States 28 945 1.9× 688 2.2× 130 0.8× 141 1.1× 57 0.9× 85 1.8k
Daniel Delorme Canada 23 812 1.6× 852 2.7× 238 1.4× 138 1.1× 19 0.3× 39 1.6k
Kurt Eger Germany 18 532 1.1× 428 1.3× 84 0.5× 69 0.6× 42 0.7× 76 1.0k
Laurent Schio France 15 486 1.0× 344 1.1× 76 0.5× 109 0.9× 14 0.2× 29 1.0k
Catherine R. Kostlan United States 11 589 1.2× 237 0.7× 40 0.2× 129 1.0× 17 0.3× 25 838
Brian E. Fink United States 17 687 1.4× 893 2.8× 426 2.6× 92 0.7× 109 1.7× 27 1.7k

Countries citing papers authored by C.L. Santos

Since Specialization
Citations

This map shows the geographic impact of C.L. Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. Santos more than expected).

Fields of papers citing papers by C.L. Santos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L. Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. Santos. The network helps show where C.L. Santos may publish in the future.

Co-authorship network of co-authors of C.L. Santos

This figure shows the co-authorship network connecting the top 25 collaborators of C.L. Santos. A scholar is included among the top collaborators of C.L. Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L. Santos. C.L. Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tang, Yanan, John R. Mackey, Raymond Lai, et al.. (2013). Quantitative proteomic analysis of HER2 normal and overexpressing MCF-7 breast cancer cells revealed proteomic changes accompanied with HER2 gene amplification. Journal of Proteomics. 91. 200–209. 7 indexed citations
3.
Dechaphunkul, Arunee, et al.. (2012). Prognostic Significance of Tissue Inhibitor of Metalloproteinase-1 in Breast Cancer. International Journal of Breast Cancer. 2012. 1–10. 36 indexed citations
4.
Damaraju, Sambasivarao, Nancy R. Zhang, Nan Li, et al.. (2009). Evidence for copurification of micronuclei in sucrose density gradient-enriched plasma membranes from cell lines. Analytical Biochemistry. 396(1). 69–75. 2 indexed citations
5.
Tsang, Roger Y., C.L. Santos, Sunita Ghosh, et al.. (2008). Immunohistochemistry for human concentrative nucleoside transporter 3 protein predicts fludarabine sensitivity in chronic lymphocytic leukemia. Modern Pathology. 21(11). 1387–1393. 11 indexed citations
6.
Damaraju, Vijaya L., Adam Elwi, Pat Carpenter, et al.. (2007). Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. American Journal of Physiology-Renal Physiology. 293(1). F200–F211. 48 indexed citations
7.
Sève, P., Tony Reiman, Raymond Lai, et al.. (2006). Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site. Cancer Chemotherapy and Pharmacology. 60(1). 27–34. 44 indexed citations
8.
Dimmock, Jonathan R., Sriram Gunda, Sarvesh C. Vashishtha, et al.. (2004). Anticonvulsants Containing the N-(3-Aryl-2-propenoyl) amido Pharmacophore. Journal of Enzyme Inhibition and Medicinal Chemistry. 19(4). 303–312. 8 indexed citations
9.
Galmarini, Carlos M., Marilyn L. Clarke, Lars Petter Jordheim, et al.. (2004). Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene. BMC Pharmacology. 4(1). 8–8. 58 indexed citations
10.
Dimmock, Jonathan R., Maniyan P. Padmanilayam, Umashankar Das, et al.. (2003). Cytotoxic Mannich Bases of 1-Arylidene-2-tetralones. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(4). 313–324. 9 indexed citations
11.
Galmarini, Carlos M., Marilyn L. Clarke, C.L. Santos, et al.. (2003). Sensitization of ara‐C‐resistant lymphoma cells by a pronucleotide analogue. International Journal of Cancer. 107(1). 149–154. 14 indexed citations
12.
Dimmock, Jonathan R., Amitabh Jha, Gordon A. Zello, et al.. (2003). 3,5-Bis(Phenylmethylene)-1-(N-arylmaleamoyl)-4-piperidones: A Novel Group of Cytotoxic Agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(4). 325–332. 18 indexed citations
13.
Dimmock, Jonathan R., Maniyan P. Padmanilayam, Gordon A. Zello, et al.. (2003). Cytotoxic analogues of 2,6-bis(arylidene)cyclohexanones. European Journal of Medicinal Chemistry. 38(2). 169–177. 87 indexed citations
14.
Dimmock, J.R., Amitabh Jha, Gordon A. Zello, et al.. (2003). Cytotoxic 4'-aminochalcones and related compounds.. PubMed. 58(4). 227–32. 12 indexed citations
15.
Dimmock, Jonathan R., Amitabh Jha, Gordon A. Zello, et al.. (2003). Cytotoxic 4′‐Aminochalcones and Related Compounds.. ChemInform. 34(32). 8 indexed citations
16.
Dimmock, Jonathan R., Gordon A. Zello, J. Wilson Quail, et al.. (2002). Cytotoxic 1,3-diarylidene-2-tetralones and related compounds. European Journal of Medicinal Chemistry. 37(10). 813–824. 36 indexed citations
17.
Dimmock, Jonathan R., Amitabh Jha, Praveen Kumar, et al.. (2002). Cytotoxic 1,4-bis(2-oxo-1-cycloalkylmethylene)benzenes and related compounds. European Journal of Medicinal Chemistry. 37(1). 35–44. 18 indexed citations
18.
19.
20.
Dimmock, Jonathan R., Maniyan P. Padmanilayam, R.N. Puthucode, et al.. (2001). A Conformational and Structure−Activity Relationship Study of Cytotoxic 3,5-Bis(arylidene)-4-piperidones and Related N-Acryloyl Analogues. Journal of Medicinal Chemistry. 44(4). 586–593. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renukadevi Patil Breakdown of academic impact, for papers by Francesca Pagliai Breakdown of academic impact, for papers by Palwinder Singh Breakdown of academic impact, for papers by Hsueh‐Yun Lee Breakdown of academic impact, for papers by John D. Chisholm Breakdown of academic impact, for papers by Daniel Delorme Breakdown of academic impact, for papers by Kurt Eger Breakdown of academic impact, for papers by Laurent Schio Breakdown of academic impact, for papers by Catherine R. Kostlan Breakdown of academic impact, for papers by Brian E. Fink
Rankless by CCL
2026